Alidad Mireskandari

ALIDAD MIRESKANDARI, PhD is currently the Portfolio Manager of the
Monument Medical Sciences Fund and is managing investments across all
sectors of the Life Sciences Industry under the direction of Bob
Grandhi, Monument Advisor’s Chief Investment Officer. Before joining the
firm, he was a Manager in the Life Sciences Industry Group at Pittiglio
Rabin Todd & McGrath, a premier global consulting firm to high
technology companies. Dr. Mireskandari consulted on development of
technology and product cycle-time improvements in the pharmaceutical and
medical devices industry. Earlier, he evaluated strategic business
opportunities in the combinatorial chemistry industry for Fisher
Scientifics’ chemical division. For the five years prior to joining
Fisher, Dr. Mireskandari was a Research Fellow at NIH’s National Cancer
Institute. In its Laboratory of Molecular Virology, he led a team
conducting analysis of Human T-cell Leukemia Virus Type-1 (HTLV-1)
infection and replication mechanisms. He earned a BS degree is Biology
and a PhD in Genetics from GWU and an MBA in Finance from the University
of Michigan Business School.

Related Interviews:

Alidad Mireskandari - Monument Funds Group Inc
February 19, 2001